TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Gland Pharma Ltd. ( (IN:GLAND) ) is now available.
Gland Pharma Limited has announced the receipt of a Confirmation Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending March 31, 2025. This certificate, issued by MUFG Intime India Private Limited, confirms the dematerialization status of securities and their listing on stock exchanges, ensuring compliance with regulatory requirements and maintaining transparency for stakeholders.
More about Gland Pharma Ltd.
Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of complex injectables. The company is known for its extensive portfolio of generic injectables and its emphasis on quality and compliance in its operations.
YTD Price Performance: -21.23%
Average Trading Volume: 11,256
Current Market Cap: 233.1B INR
For detailed information about GLAND stock, go to TipRanks’ Stock Analysis page.